日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer

依替尼康聚乙二醇(NKTR-102)用于治疗肺癌或乳腺癌脑转移患者

Nagpal, Seema; Nguyen, Kim-Son; Bertrand, Sophie; Cunanan, Kristen May; Padda, Sukhmani K; Pagtama, Judy Y; Tisch, Alison Holmes; Coffey, Gwen; Thomas, Reena P; Sledge, George W Jr; Gruber, Joshua; Telli, Melinda L; Pegram, Mark; Recht, Lawrence D; Wakelee, Heather A; Soltys, Scott G; Massarweh, Suleiman A; Neal, Joel W

Molecular Characterization and Mortality From Breast Cancer in Men

男性乳腺癌的分子特征与死亡率

Massarweh, Suleiman Alfred; Sledge, George W; Miller, Dave P; McCullough, Debbie; Petkov, Valentina I; Shak, Steven

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

AP-1阻断可增强内分泌治疗效果并克服耐药性

Malorni, Luca; Giuliano, Mario; Migliaccio, Ilenia; Wang, Tao; Creighton, Chad J; Lupien, Mathieu; Fu, Xiaoyong; Hilsenbeck, Susan G; Healy, Nuala; De Angelis, Carmine; Mazumdar, Abhijit; Trivedi, Meghana V; Massarweh, Suleiman; Gutierrez, Carolina; De Placido, Sabino; Jeselsohn, Rinath; Brown, Myles; Brown, Powel H; Osborne, C Kent; Schiff, Rachel

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.

在转移性雌激素受体阳性乳腺癌的内分泌治疗中加入多激酶抑制剂索拉非尼的影响

Massarweh Suleiman, Moss Jessica, Wang Chi, Romond Edward, Slone Stacey, Weiss Heidi, Karabakhtsian Rouzan G, Napier Dana, Black Esther P

Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies

在获得对内分泌治疗和HER2靶向治疗耐药的ER阳性/HER2过表达乳腺癌异种移植瘤中,黏蛋白4表达上调

Chen, Albert C; Migliaccio, Ilenia; Rimawi, Mothaffar; Lopez-Tarruella, Sara; Creighton, Chad J; Massarweh, Suleiman; Huang, Catherine; Wang, Yen-Chao; Batra, Surinder K; Gutierrez, M Carolina; Osborne, C Kent; Schiff, Rachel

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

一项针对新诊断的雌激素受体阳性乳腺癌患者的阿那曲唑、氟维司群和吉非替尼新辅助治疗的II期临床试验

Massarweh, Suleiman; Tham, Yee L; Huang, Jian; Sexton, Krystal; Weiss, Heidi; Tsimelzon, Anna; Beyer, Amanda; Rimawi, Mothaffar; Cai, Wei Yen; Hilsenbeck, Susan; Fuqua, Suzanne; Elledge, Richard

Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts

对靶向治疗产生耐药性会改变乳腺肿瘤异种移植瘤的临床相关分子特征亚型。

Creighton, Chad J; Massarweh, Suleiman; Huang, Shixia; Tsimelzon, Anna; Hilsenbeck, Susan G; Osborne, C Kent; Shou, Jiang; Malorni, Luca; Schiff, Rachel